EP. 1: Patient Awareness of Biosimilars and Loyalty to Branded Drugs
EP. 2: Patient Savings From Biosimilars
EP. 3: Barriers to Biosimilars for Oncology Patients
EP. 4: Biosimilars, Payers, and Formulary Changes
EP. 5: The Exceptions Process and its Effect on Patients
EP. 6: Patient Education on Coverage for Biologics and Biosimilars
EP. 7: Alternative Payment Models and Patient Care
EP. 8: The Cost of Biologics and Biosimilars
EP. 9: Rebates and Medicare Part D
EP. 10: CMS' Changes to Reimbursement for Biosimilars
EP. 11: Biosimilars, Private Payers, and Pharmacy-Level Substitution
EP. 12: Patient Assistance Programs and Biosimilars
EP. 13: Manufacturers and the Cost of Biosimilars and Biologics
EP. 14: Diversity in Clinical Trials for Biosimilars
EP. 15: The FDA and Diversity in Clinical Trials
EP. 16: Oncology Biosimilars Making a Difference for Patients
EP. 17: Putting Patients at the Center of the Biosimilar Conversation
